These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
559 related articles for article (PubMed ID: 17408464)
1. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma. Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of monoclonal protein in 72 cases of multiple myeloma]. Yang JJ; Zhang GS; Chen XR Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients. García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836 [TBL] [Abstract][Full Text] [Related]
4. Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents. Maltezas D; Dimopoulos MA; Katodritou I; Repousis P; Pouli A; Terpos E; Panayiotidis P; Delimpasi S; Michalis E; Anargyrou K; Gavriatopoulou M; Stefanoudaki A; Tzenou T; Koulieris E; Sachanas S; Dimou M; Vassilakopoulos TP; Angelopoulou MK; Pangalis GA; Kyrtsonis MC Hematol Oncol; 2013 Jun; 31(2):96-102. PubMed ID: 22961993 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma]. Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965 [TBL] [Abstract][Full Text] [Related]
7. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof]. Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880 [TBL] [Abstract][Full Text] [Related]
8. [Biochemical and immunological findings of multiple myeloma]. Asaoku H Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270 [TBL] [Abstract][Full Text] [Related]
9. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676 [TBL] [Abstract][Full Text] [Related]
10. [Value of Serum Free Light Chain Kappa/Lambda Ratio Detection Combined with Immunofixation Electrophoresis in the Prognosis Evaluation of Patients with Multiple Myeloma]. Jiang XN; Chen JF; Wang Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):191-195. PubMed ID: 32027275 [TBL] [Abstract][Full Text] [Related]
11. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay. Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067 [TBL] [Abstract][Full Text] [Related]
12. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma. Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271 [TBL] [Abstract][Full Text] [Related]
13. [The roles of serum free light chain ratio in the diagnosis and prognosis of newly diagnosed multiple myeloma]. Wang PF; Xu Y; Yan S; Yao Y; Zheng HF; Ma L; Jin S; Xu Y; Gong FR; Zhou JZ; Chang HR; Fu CC Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):377-82. PubMed ID: 27210871 [TBL] [Abstract][Full Text] [Related]
14. Polyclonal free light chain of Ig may interfere with interpretation of monoclonal free light chain κ/λ ratio. Levinson SS Ann Clin Lab Sci; 2010; 40(4):348-53. PubMed ID: 20947809 [TBL] [Abstract][Full Text] [Related]
15. A case of hook effect in the serum free light chain assay using the Olympus AU400e. McCudden CR; Voorhees PM; Hammett-Stabler CA Clin Biochem; 2009 Jan; 42(1-2):121-4. PubMed ID: 18996106 [TBL] [Abstract][Full Text] [Related]
16. [Detection of serum free light chain and its clinical significance in nonsecretory multiple myeloma]. Chen HF; Hou J; Yuan ZG; Wang DX; Fu WJ; Chen YB Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):113-6. PubMed ID: 18681313 [TBL] [Abstract][Full Text] [Related]
17. The evolving use of serum free light chain assays in haematology. Pratt G Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757 [TBL] [Abstract][Full Text] [Related]
18. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291 [TBL] [Abstract][Full Text] [Related]
19. Serum free light chains: diagnostic and prognostic value in multiple myeloma. Sthaneshwar P; Nadarajan V; Maniam JA; Nordin N; Gin Gin G Clin Chem Lab Med; 2009; 47(9):1101-7. PubMed ID: 19728852 [TBL] [Abstract][Full Text] [Related]
20. Normalization of free light chain kappa/lambda ratio is a robust prognostic indicator of favorable outcome in patients with multiple myeloma. Iwama K; Chihara D; Tsuda K; Ugai T; Sugihara H; Nishida Y; Yamakura M; Takeuchi M; Matsue K Eur J Haematol; 2013 Feb; 90(2):134-41. PubMed ID: 23210517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]